Service Corp. <SCI.N>: BofA Global Research Raises Price Objective to $100.00 From $98.00
SCI•Related News
Celcuity says NCCN guidelines add newly FDA-approved REVTORPYK for advanced HR+/HER2- breast cancer
CELC•
Prog Holdings Inc <PRG.N>: B. Riley raises target price to $64 from $57
PRG•
Cemtrex's Vicon Secures Approximately $900,000 Order To Equip U.S. Corrections Facility End-To-End
CETX•
PennDOT partners with Liquidity Services’ GovDeals for statewide online auction of 350 surplus assets
LQDT•
US weekly jobless claims increase less than expected
SPY•